← Back to catalogue

EXCI308 by Aerolase

FDA UDI

Class II (US FDA UDI)

by Clarteis

Identity

Trade Name
EXCI308 by Aerolase FDA UDI
Generic Name
Ultraviolet phototherapy unit, professional FDA UDI
Device Name
Exci308® by Aerolase This medical device is intended to be used for the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. Excimer light source, wavelength 308nm, optical power 2500 mW. FDA UDI
Model / Reference
EIPL-100 FDA UDI
Description
Exci308® by Aerolase This medical device is intended to be used for the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. Excimer light source, wavelength 308nm, optical power 2500 mW. FDA UDI

Identifiers

Catalog Number
EIPL-PRD-K01-exci308 FDA UDI
Primary DI / UDI-DI
03760313461017 FDA UDI
510(k) Number
K191086 FDA UDI
FDA Product Code
FTC FDA UDI
GMDN Term
Ultraviolet phototherapy unit, professional FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
878.4630 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Ultraviolet phototherapy unit, professional

EXCI308 by Aerolase by Clarteis — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Ultraviolet phototherapy unit, professional.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Clarteis

Sources (1)

  • FDA UDI 58f9eb47-b6ac-4b9a-91dd-88f5d58d441d 36 fields · synced May 30, 2026